Met Life Investment Management, LLC Vigil Neuroscience, Inc. Transaction History
Met Life Investment Management, LLC
- $14.7 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding VIGL
# of Institutions
54Shares Held
26.7MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$23.3 Million2.49% of portfolio
-
Northpond Ventures, LLC4.21MShares$16.9 Million40.32% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.17MShares$8.66 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$7.25 Million0.19% of portfolio
-
Artal Group S.A. Luxembourg, N41.81MShares$7.24 Million0.33% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $113M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...